Selective Binding Agents Of Telomerase

Abstract

The present invention relates to novel selective binding agents including polyclonal and monoclonal antibodies that recognize and bind to the catalytic subunit of human telomerase (hTERT). The invention also relates to the production, diagnostic use, and therapeutic use of the hTERT antibodies and fragments thereof.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 18, 2006
  • Application: Sep 20, 2001
    US US 95715701 A
  • Priority: Sep 20, 2001
    US US 95715701 A
  • Priority: Sep 21, 2000
    US US 23444100 P

Download Citation


Sign in to the Lens

Feedback